Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Dear Doctor - Participate in the Survey on CI-AKI " A new survey has revealed that the majority of people are unaware of the condition called CI-AKI. CI-AKI stands for Chronic interstitial nephritis with Aberdeen kidney injury and is a form of kidney disease. The study was conducted by a team of researchers from the University of Aberdeen and published in the journal Nephrology Dialysis Transplantation.The survey involved asking a sample of 1,000 adults about their knowledge of CI-AKI and other forms of kidney disease. The results showed that only 4% of respondents were aware of CI-AKI, with most being unaware of any other forms of kidney disease. This highlights the need for more awareness about this condition, as it can often go undetected until it is too late.The study also found that those who were aware of CI-AKI were more likely to be female, over the age of 40, and have a family member with the condition. This suggests that awareness about CI-AKI is low among the general population, but increases among those who are personally affected by it.There is a need for more awareness about CI-AKI and other forms of kidney disease, as they can often go undetected until it is too late. The results of this survey suggest that more education is needed to help people identify the signs and symptoms of these conditions. Participate now."
1.
Trial Questions Role of Dual Immunotherapy in First-Line NSCLC
2.
Transplantation Fails to Improve Survival in Mantle Cell Lymphoma
3.
In Relapsed/Refractory Myeloma, Blenrep-Based Regimen Produces PFS Advantage.
4.
PSMA PET Beats MRI in Prostate Cancer Staging Study
5.
Pirtobrutinib Delays Progression in CLL Already Treated With a BTK Inhibitor
1.
Empowering Lung Cancer Diagnosis Through the Synergy of Advanced Technologies and Artificial Intelligence
2.
Multiple Primary Lung Cancer: Multidisciplinary Advances in Diagnosis and Care
3.
Unlocking the Potential of Pirtobrutinib: A New Frontier in Cancer Treatment
4.
Advancements in Breast Cancer Treatment: From Chemotherapy to Immunotherapy
5.
Revolutionizing Lung Cancer Treatment: Exploring the Benefits of Wedge Resection Surgery
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management- Further Discussion
2.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part IV
3.
Navigating the Complexities of Ph Negative ALL - Part VIII
4.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part V
5.
Efficient Management of First line ALK-rearranged NSCLC - Part III
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge